Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
American Journal of Pharmaceutical Education
|
February 7, 2015
A workshop series using peer-grading to build drug information, writing, critical-thinking, and constructive feedback skills
Lindsay E Davis
The Journal of Continuing Education in the Health Professions
|
April 30, 2021
Fostering Mindfulness in Continuing Pharmacy Education Using a Board Game: Initial Experiences and Perceptions
Elizabeth K Pogge, Lindsay E Davis
JAAPA : Official Journal of the American Academy of Physician Assistants
|
May 20, 2015
Should patients with chronic liver disease receive venous thromboembolism prophylaxis?
Justin D Dang, Lindsay E Davis
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
February 19, 2018
Evaluating the Safety and Tolerability of Sacubitril/Valsartan for HFrEF Managed Within a Pharmacist Clinic
Elizabeth K Pogge, Lindsay E Davis
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
|
July 12, 2020
A Retrospective Chart Review Evaluating Efficacy, Tolerability, and Cost of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i) in Older Adults
Lindsay E Davis, Elizabeth K Pogge
JAAPA : Official Journal of the American Academy of Physician Assistants
|
June 30, 2018
Combined angiotensin receptor and neprilysin inhibition therapy for heart failure
Becky N Lu, Lindsay E Davis
The Senior Care Pharmacist
|
October 30, 2022
Geriatric Pharmacotherapy Case Series: Neurogenic Orthostatic Hypotension
Elizabeth K Pogge, Lindsay E Davis
The Annals of Pharmacotherapy
|
August 30, 2021
Outcome Benefits Seen With 1 Year of Optimized Sacubitril/Valsartan for the Treatment of Systolic Heart Failure Managed by Pharmacists in a Cardiology Practice
Lindsay E Davis, Elizabeth K Pogge
JAAPA : Official Journal of the American Academy of Physician Assistants
|
February 23, 2023
Are beta-blockers safe and effective after myocardial infarction in patients with COPD?
Lindsay E Davis, Elizabeth K Pogge, Rajeev Garg
The Journal of Cardiovascular Nursing
|
December 13, 2017
The Diuretic Potential of Sacubitril/Valsartan: A Tale of 2 Patients
Sabrina M Hormann, Lindsay E Davis, Elizabeth K Pogge
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
American Journal of Pharmaceutical Education
|
February 7, 2015
A workshop series using peer-grading to build drug information, writing, critical-thinking, and constructive feedback skills
Lindsay E Davis
The Journal of Continuing Education in the Health Professions
|
April 30, 2021
Fostering Mindfulness in Continuing Pharmacy Education Using a Board Game: Initial Experiences and Perceptions
Elizabeth K Pogge, Lindsay E Davis
JAAPA : Official Journal of the American Academy of Physician Assistants
|
May 20, 2015
Should patients with chronic liver disease receive venous thromboembolism prophylaxis?
Justin D Dang, Lindsay E Davis
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
February 19, 2018
Evaluating the Safety and Tolerability of Sacubitril/Valsartan for HFrEF Managed Within a Pharmacist Clinic
Elizabeth K Pogge, Lindsay E Davis
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
|
July 12, 2020
A Retrospective Chart Review Evaluating Efficacy, Tolerability, and Cost of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i) in Older Adults
Lindsay E Davis, Elizabeth K Pogge
JAAPA : Official Journal of the American Academy of Physician Assistants
|
June 30, 2018
Combined angiotensin receptor and neprilysin inhibition therapy for heart failure
Becky N Lu, Lindsay E Davis
The Senior Care Pharmacist
|
October 30, 2022
Geriatric Pharmacotherapy Case Series: Neurogenic Orthostatic Hypotension
Elizabeth K Pogge, Lindsay E Davis
The Annals of Pharmacotherapy
|
August 30, 2021
Outcome Benefits Seen With 1 Year of Optimized Sacubitril/Valsartan for the Treatment of Systolic Heart Failure Managed by Pharmacists in a Cardiology Practice
Lindsay E Davis, Elizabeth K Pogge
JAAPA : Official Journal of the American Academy of Physician Assistants
|
February 23, 2023
Are beta-blockers safe and effective after myocardial infarction in patients with COPD?
Lindsay E Davis, Elizabeth K Pogge, Rajeev Garg
The Journal of Cardiovascular Nursing
|
December 13, 2017
The Diuretic Potential of Sacubitril/Valsartan: A Tale of 2 Patients
Sabrina M Hormann, Lindsay E Davis, Elizabeth K Pogge
Page
of 3